BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38099414)

  • 1. Inhibitor of Wnt receptor 1 suppresses the effects of Wnt1, Wnt3a and β‑catenin on the proliferation and migration of C6 GSCs induced by low‑dose radiation.
    Yan Y; Cheng YY; Li YR; Jiao XW; Liu YM; Cai HY; Ding YX
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PER2 inhibits proliferation and stemness of glioma stem cells via the Wnt/β‑catenin signaling pathway.
    Ma D; Hou L; Xia H; Li H; Fan H; Jia X; Niu Z
    Oncol Rep; 2020 Aug; 44(2):533-542. PubMed ID: 32468039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
    Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
    Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization.
    Chen X; Lu Y; Guo G; Zhang Y; Sun Y; Guo L; Li R; Nan Y; Yang X; Dong J; Jin X; Huang Q
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway.
    Miao J; Jiang Y; Wang D; Zhou J; Fan C; Jiao F; Liu B; Zhang J; Wang Y; Zhang Q
    Oncol Rep; 2015 Dec; 34(6):2845-52. PubMed ID: 26397053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling.
    Wu Q; Yin X; Zhao W; Xu W; Chen L
    PLoS One; 2021; 16(12):e0260864. PubMed ID: 34852024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
    Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling.
    Luo G; Luo W; Sun X; Lin J; Wang M; Zhang Y; Luo W; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):187-193. PubMed ID: 27909726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
    Qian C; Liu Q
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
    Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
    Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
    Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling.
    Yin J; Ding F; Cheng Z; Ge X; Li Y; Zeng A; Zhang J; Yan W; Shi Z; Qian X; You Y; Ding Z; Ji J; Wang X
    Cell Death Dis; 2023 Jul; 14(7):417. PubMed ID: 37438359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑301a targets WNT1 to suppress cell proliferation and migration and enhance radiosensitivity in esophageal cancer cells.
    Su H; Wu Y; Fang Y; Shen L; Fei Z; Xie C; Chen M
    Oncol Rep; 2019 Jan; 41(1):599-607. PubMed ID: 30365079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro RNA-640 Targeting SLIT1 Enhances Glioma Radiosensitivity by Restraining the Activation of Wnt/β-Catenin Signaling Pathway.
    Zheng Y; Xiao M; Zhang J; Chang F
    Br J Biomed Sci; 2022; 79():10067. PubMed ID: 35996510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.